A Study of LY3549492 in Healthy Participants

NCT04758234 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3549492
DRUG: Placebo

Sponsor

Eli Lilly and Company